Clinical Trials Directory

Trials / Unknown

UnknownNCT04174950

Perioperative ERAS Based Nursing Intervention for Laryngeal Cancer Patients

Effect of Perioperative ERAS Based Nursing Intervention on Hope Level of Patients With Laryngeal Cancer

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

To explore the effect of perioperative ERAS based nursing model on the hope level and recovery of patients with laryngeal cancer.

Detailed description

200 patients who were diagnosed with laryngeal cancer and received total or partial laryngectomy were included. They were allocated into experimental and control group. Patients in experimental group were given ERAS based nursing intervention. Control group were given routine nursing intervention. Compare hope level, postoperative recovery, complication between two groups.

Conditions

Interventions

TypeNameDescription
OTHERRoutine nursing careroutine perioperative nursing intervention, including intensive observation of vital signs, preoperative education, postoperative communication and instruction on diet. NPO after the dinner one day before operation. Patients are instructed to NPO 3 days after surgery and patients should stay on the bed for 3 days. Urinary catheter is always kept for 48 hours or more.
OTHERPerioperative Enhanced Recovery After Surgery (ERAS) Based Nursing ModelEstablish ERAS nursing team and formulate ERAS nursing intervention. Nothing by mouth (NPO) 6 hours before operation and no water 4 hours before operation. Patients are given fluid food 24 hours after surgery. Urinary catheter is removed within 24 hours after surgery and encourage patient to mobile 24 hours after surgery. Give support to pain control and psychological support. Intensive observation of vital signs, preoperative education, postoperative communication and instruction on diet were also given to patients.

Timeline

Start date
2018-09-14
Primary completion
2020-06-30
Completion
2020-10-31
First posted
2019-11-22
Last updated
2019-11-22

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04174950. Inclusion in this directory is not an endorsement.